Subscribe to The Post Most newsletter for the most important and interesting stories from. If you’ve ever had a urinary tract infection, you know the misery - the frequency, ...

Gaffin is an infectious disease physician in New Jersey. Recently, a former patient contacted me about his wife. “She had a recent stroke which has caused cognitive decline along with slow-growing ...

AutoZone shares have crushed the S&P 500 in the past five years. The products this company sells register durable demand, making it a safe holding in any economic situation. For those investors who ...

Good day, everyone, and welcome to AutoZone's 2026 Q1 Earnings Release Conference Call. [Operator Instructions] At this time, the company would like to provide its forward-looking statement. Before we ...

Fintel reports that on November 13, 2025, Goldman Sachs upgraded their outlook for AutoZone (NYSE:AZO) from Neutral to Buy. Analyst Price Forecast Suggests 22.91% Upside As of November 9, 2025, the ...

AutoZone (AZO) delivered a mixed fiscal 4Q25 report, marked by a fifth consecutive EPS miss despite solid topline performance. The company’s ongoing expansion and solid same store sales growth ...

Writing this story is admittedly a personal endeavor, as I’m no stranger to recurring urinary tract infections, nor how painful and disruptive they can be. If there was ever going to be a solid ...

Erin A. Brennand receives funding from the Canadian Institutes of Health Research, Social Sciences and Humanities Research Council, the Calgary Health Foundation, and the MSI Foundation (all paid to ...

Many women have, for decades, taken a drug called phenazopyridine to control pain from urinary tract infections that has not been vetted or approved by the Food and Drug Administration. Consumers and ...

Many women have, for decades, taken a drug called phenazopyridine to control pain from urinary tract infections. Sold under such brand names as Azo and Uristat, it’s available in most US pharmacies or ...